DayOne - Healthcare Innovation ’s Post

Another Open mic: next in health series is in the books!    This time, we tackled the topic of integrating healthtech in clinical trials: smarter data collection and analysis. Our expert speakers and engaged audience dove into a lively discussion of this timely subject.   A huge thank you to everyone who joined us, and a special shoutout to our amazing speakers—Poorya Amini, Ieuan Clay, and Mara Hummel—for sharing their invaluable insights and experiences. Here are some of our key takeaways: 💡 Clinical trials focus on developing new treatments, not innovating. This impacts speed and adoption of healthtech in clinical trials. 💡 Early healthtech integration (Phase II-III) is key but often starts too late, after sales targets arise. 💡A molecule’s full life cycle guides when and what innovations to integrate into trials. 💡Reducing time to market boosts profitability and speeds therapy access for patients. 💡Technology shapes drug development: from protocol design to patient engagement to data optimization. 💡Current standalone solutions lack a “killer app” for seamless integration across processes.   We’re also grateful to Novartis for sponsoring the stunning venue and Apéro.   Exciting news: our series will be back next year! Want to be in the loop? Sign up to receive our next invitation straight to your inbox.   Stay tuned for the event recording—it’s coming soon! Meanwhile, enjoy some snapshots 📸   Ursula Costa | Rahel Schneider | Morgane Husser | Arianna Carolina R. | Caoimhe Vallely-Gilroy | Cécile Tardy-Srinivasan   #healthtech #clinicaltrials #datacollection #dataanalysis #patientengagement #innovation